VKTX - Viking Therapeutics, Inc

Healthcare - Sector

VKTX is currently covered by 1 analysts with average potential upside of $6.24 (81.57%) backed by 11 price targets and 20 ratings. Analyst's average stock valuation to be materialised ratio is 35.42% with an average time for price targets to be met of 64.25 days.

Most recent stock forecast was given by STEVEN SEEDHOUSE from RAYMOND JAMES on 27-Oct-2022.

Highest price target for VKTX is 6, Lowest price target is 4, average price target is 5.

Best performing analysts who are covering VKTX - Viking Therapeutics, Inc:

Jason Mccarthy Scott Henry Steven Seedhouse Michael Morabito

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

11

$7.24 (192.55%)

10

1 months 12 days ago

1/4 (25%)

$6.27 (121.94%)

82

Buy

15

2 years 3 months 11 days ago

0/1 (0%)

$7.56 (101.61%)

Buy

28

3 years 8 months 25 days ago

2/3 (66.67%)

$5.74 (45.06%)

107

Buy

24

$20.24 (538.30%)

24

4 years 1 months ago

2/4 (50%)

$5.38 (57.66%)

68

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login